Thornberry Nancyinsider trades

In SEC Form 4 filings, Thornberry Nancy is listed as Director of Denali Therapeutics Inc. (DNLI). In the last 90 days, Thornberry Nancy sold $261.9K of Denali Therapeutics Inc. (DNLI) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
DNLIDenali Therapeutics Inc.	Director	2	Sep 4

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-04

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
DNLIDenali Therapeutics Inc.	Sep 2	Sep 4	S	10,824	$22.85	Sale −$247,328	20,301	Yes	Form 4
DNLIDenali Therapeutics Inc.	Sep 2	Sep 4	S	615	$23.74	Sale −$14,600	19,686	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.